Cyber Valley grants 500K to CELL’n’ROLL via 2023 Innovation Fellowship Program

Stuttgart - Pioneering cutting-edge diagnostic systems for the detection of complex diseases: Cyber Valley is pleased to announce it has awarded funding of 500K EUR to the CELL’n’ROLL team through the 2023 Cyber Valley Innovation Fellowship program, funded by the Carl-Zeiss-Stiftung.

CELL’n’ROLL aims to develop next-generation diagnostic solutions for detecting complex diseases such as cancer. Leveraging robotics, artificial intelligence, and microtechnology, the initiative aims to democratize access to these diagnostic tools worldwide. CELL’n’ROLL envisions a future where diagnostics are not only swift and precise but also accessible in resource-constrained settings by harnessing the power of robotics, artificial intelligence, and microfluidics.

The CELL’n’ROLL team consists of Postdoctoral Researchers Alp Can Karacakol, Erdost Yildiz, and the project leader Ugur Bozuyuk. As emerging scientific talents, the team comprises three scientists from the Max Planck Institute for Intelligent Systems, each with interdisciplinary expertise spanning medicine and engineering, and a collective experience exceeding three years of collaboration. Additionally, the team benefits from mentorship provided by international experts from academia and industry.

The Innovation Fellowship program will support their journey from outstanding research to practical application. The program’s aim is to bridge the gap between research and commercial application by fostering scientific breakthroughs that add value to science, economy, and society. The Innovation Fellowship program is funded by the Carl-Zeiss-Stiftung (CZS) and offers talented individuals or teams the opportunity to translate their research into tangible applications. With a duration of up to 24 months, researchers work on a project that is not yet commercially viable and requires time for further development and product transformation in a research environment. The program focuses on application-oriented research related to artificial intelligence and robotics. Its goal is to create an innovative spin-off from the project after the funding term has ended.  

About CELL’n’ROLL
CELL’n’ROLL, established two years ago, is driven by a team of three dedicated postdoctoral researchers with varied expertise, spanning engineering and medicine. Their collective passion lies in pioneering cutting-edge diagnostic systems for the detection of complex diseases, such as cancer. They envision a future where diagnostics are not only swift and precise but also accessible in resource-constrained settings by harnessing the power of robotics, artificial intelligence, and microfluidics.

About Cyber Valley  
Cyber Valley is Europe’s largest and leading center for excellence in artificial intelligence and modern robotics. Its mission and public mandate are to advocate for research, development, application, and acceptance of technologies and methods in the field of intelligent systems. Cyber Valley encourages entrepreneurship by uniting scientific excellence with innovation and technology transfer. In addition, Cyber Valley facilitates critical reflection on the ethical and social implications of AI through public engagement. Cyber Valley envisions a future in which the full potential of intelligent systems is leveraged for the greater good of the world. Cyber Valley GmbH, with locations in Stuttgart in Tübingen, is owned by the State of Baden-Württemberg and the Max Planck Society.  
 

About the Carl-Zeiss-Stiftung
The Carl-Zeiss-Stiftung’s mission is to create an open environment for scientific breakthroughs. As a partner of excellence in science, it supports basic research as well as applied sciences in the STEM subject areas (science, technology, and mathematics). Founded in 1889 by the physicist and mathematician Ernst Abbe, the Carl-Zeiss-Stiftung is one of the oldest and biggest private science funding institutions in Germany. It is the sole owner of Carl Zeiss AG and SCHOTT AG. Its projects are financed from the dividend distributions of the two foundation companies.